KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

LEASES (Tables)

3 Months Ended

Mar. 31, 2020

The components of lease expense were as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019

Operating lease cost	$	37,922	$	35,829

Finance lease cost:
Amortization of right-of-use assets	$	1,856	$	1,060
Interest on lease liabilities		87		72
Total finance lease cost	$	1,943	$	1,132

Supplemental cash flow information related to leases was as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019

Cash paid for amounts included in the measurement of lease liabilities:
Finance cash flows from finance leases	$	1,848	$	1,028
Finance lease cost:
Amortization of right-of-use assets	$	1,856	$	1,060
Interest on lease liabilities		87		72
Total finance lease cost	$	1,943	$	1,132

Supplemental balance sheet information related to leases was as follows:


	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019

Operating Leases
Operating lease right-of-use assets	$	340,118		$	472,224

Operating lease current liabilities	$	138,520		$	131,845
Operating lease long term liabilities		201,598			340,379
Total operating lease liabilities	$	340,118		$	472,224

Finance Leases
Property and equipment, at cost	$	12,725		$	6,363
Accumulated depreciation		(6,693	)		(1,060	)
Property and equipment, net	$	6,032		$	5,303

Finance lease current liabilities	$	4,252		$	4,241
Finance lease long term liabilities		1,842			1,094
Total finance lease liabilities	$	6,094		$	5,335


	Three Months Ended March 31, 2020	Three Months Ended March 31, 2019
Weighted Average Remaining Lease Term
Operating leases	2 Years	3 Years
Finance leases	1 Year	1 Year

Weighted Average Discount Rate
Operating leases	4.75%	4.75%
Finance leases	4.75%	4.75%

Maturities of lease liabilities are as follows: